Eledon Pharmaceuticals (ELDN) Cash & Equivalents (2013 - 2026)
Eledon Pharmaceuticals posted quarterly Cash & Equivalents of $111.1 million for Q1 2026, up 1207.67% year-on-year from $8.5 million in Q1 2025, and up 387.11% on a QoQ basis from $22.8 million in Q4 2025.
Eledon Pharmaceuticals (ELDN) has 14 years of Cash & Equivalents data on file, last reported at $111.1 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Equivalents rose 1207.67% year-over-year to $111.1 million; the trailing twelve-month figure through Mar 2026 stood at $111.1 million (up 1207.67% YoY), and the FY2025 full-year result was $22.8 million, up 10.99% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $111.1 million, up from $22.8 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $111.1 million in Q1 2026 and bottomed at $4.6 million in Q4 2023.
- The 5-year median for Cash & Equivalents is $22.8 million (2025), against an average of $37.3 million.
- The widest annual swing landed in 2023, when Cash & Equivalents sank 91.82%; it then soared 1283.5% in 2025.
- A 5-year view of Cash & Equivalents shows it stood at $56.4 million in 2022, then tumbled by 91.82% to $4.6 million in 2023, then soared by 345.56% to $20.5 million in 2024, then grew by 10.99% to $22.8 million in 2025, then surged by 387.11% to $111.1 million in 2026.
- The last three Cash & Equivalents figures came in at $111.1 million (Q1 2026), $22.8 million (Q4 2025), and $93.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 1.91 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 5.49 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.96 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.71 Bn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | 111.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 111.10 Mn |
| Dec 31, 2025 | 22.81 Mn |
| Sep 30, 2025 | 93.40 Mn |
| Jun 30, 2025 | 5.74 Mn |
| Mar 31, 2025 | 8.50 Mn |
| Dec 31, 2024 | 20.55 Mn |
| Sep 30, 2024 | 6.75 Mn |
| Jun 30, 2024 | 26.04 Mn |
| Mar 31, 2024 | 42.90 Mn |
| Dec 31, 2023 | 4.61 Mn |
| Sep 30, 2023 | 59.60 Mn |
| Jun 30, 2023 | 71.40 Mn |
| Mar 31, 2023 | 9.40 Mn |
| Dec 31, 2022 | 56.41 Mn |
| Sep 30, 2022 | 9.20 Mn |
| Jun 30, 2022 | 9.20 Mn |
| Mar 31, 2022 | 76.68 Mn |
| Dec 31, 2021 | 84.83 Mn |
| Sep 30, 2021 | 94.04 Mn |
| Jun 30, 2021 | 9.20 Mn |
| Mar 31, 2021 | 9.20 Mn |
| Dec 31, 2020 | 9.20 Mn |
| Sep 30, 2020 | 10.10 Mn |
| Jun 30, 2020 | 8.76 Mn |
| Mar 31, 2020 | 8.76 Mn |
| Dec 31, 2019 | 8.79 Mn |
| Sep 30, 2019 | 10.81 Mn |
| Jun 30, 2019 | 13.70 Mn |
| Mar 31, 2019 | 13.70 Mn |
| Dec 31, 2018 | 12.97 Mn |
| Sep 30, 2018 | 16.32 Mn |
| Jun 30, 2018 | 19.19 Mn |
| Mar 31, 2018 | 22.52 Mn |
| Dec 31, 2017 | 17.30 Mn |
| Sep 30, 2017 | 19.16 Mn |
| Jun 30, 2017 | 22.58 Mn |
| Mar 31, 2017 | 24.40 Mn |
| Dec 31, 2016 | 1.12 Mn |
| Sep 30, 2016 | 18.63 Mn |
| Jun 30, 2016 | 12.16 Mn |
| Mar 31, 2016 | 14.30 Mn |
| Dec 31, 2015 | 24.02 Mn |
| Sep 30, 2015 | 33.17 Mn |
| Jun 30, 2015 | 59.08 Mn |
| Mar 31, 2015 | 94.16 Mn |
| Dec 31, 2014 | 105.26 Mn |
| Sep 30, 2014 | 105.46 Mn |
| Jun 30, 2014 | 21.15 Mn |
| Mar 31, 2014 | 27.01 Mn |
| Dec 31, 2013 | 31.75 Mn |
| Sep 30, 2013 | 23.11 Mn |